H.LUNDBECK 25/29 MTNH.LUNDBECK 25/29 MTNH.LUNDBECK 25/29 MTN

H.LUNDBECK 25/29 MTN

No trades
See on Supercharts

Key terms


Outstanding amount
‪500.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
3.38% (Fixed)
Coupon frequency
Annual
Yield to maturity
3.34%
Maturity date
Jun 2, 2029
Term to maturity
3 years

About H.LUNDBECK 25/29 MTN


Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
Issue date
Jun 2, 2025
ISIN
XS3081808837
FIGI
BBG01V42TSR9
H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Markets. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

See how H. Lundbeck A/S is moving with its highest-yielding bonds.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.